Stage IIIB Prostate Cancer AJCC v8 Clinical Trial
Official title:
A Pragmatic Phase 2 Study of Focal Ablation (Focal Cryotherapy or High Intensity Frequency Ultrasound) in Men With Clinically Localized Prostate Cancer
This clinical trial evaluates the effectiveness of focal ablation with either focal cryotherapy or high intensity frequency ultrasound for the treatment of men with localized prostate cancer. Focal cryotherapy kills tumor cells by freezing them. High intensity frequency ultrasound uses highly focused ultrasound waves to produce heat and destroy tumor cells.
PRIMARY OBJECTIVE: I. To determine the efficacy of focal therapy for treatment of prostate cancer. SECONDARY OBJECTIVES: I. Patient reported urinary, sexual function and quality of life (QOL) at 1 year. II. To assess safety. OUTLINE: Patients undergo focal cryotherapy or high intensity focused ultrasound on study. After completion of study treatment, patients are followed up at 7-14 days and periodically for up to 3 years. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03218826 -
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery
|
Phase 1 | |
| Recruiting |
NCT04981834 -
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
|
N/A | |
| Completed |
NCT04976257 -
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion
|
Early Phase 1 | |
| Suspended |
NCT03899987 -
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
|
Phase 2 | |
| Suspended |
NCT05676463 -
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03570827 -
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
|
Phase 2 | |
| Recruiting |
NCT04134260 -
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT06067269 -
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
|
Phase 2 | |
| Recruiting |
NCT05806515 -
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
|
Phase 2 | |
| Completed |
NCT03177460 -
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05320406 -
RElugolix VErsus LeUprolide Cardiac Trial
|
Phase 4 | |
| Completed |
NCT04067960 -
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer
|
Early Phase 1 | |
| Recruiting |
NCT05627219 -
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
|
||
| Suspended |
NCT04037254 -
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer
|
Phase 2 | |
| Completed |
NCT03784677 -
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Withdrawn |
NCT04288336 -
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
|
Early Phase 1 | |
| Active, not recruiting |
NCT03575832 -
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
|
N/A | |
| Active, not recruiting |
NCT03581500 -
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT04189770 -
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
|
||
| Recruiting |
NCT04725903 -
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
|
N/A |